PCRX(PCRX)
PCRX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $756M | $796M | $909M | $860M | $867M |
| Low | $723M | $774M | $794M | $822M | $829M |
| High | $804M | $819M | $1.16B | $914M | $921M |
| EBITDA Avg | $130M | $137M | $156M | $148M | $149M |
| Low | $124M | $133M | $137M | $141M | $143M |
| High | $138M | $141M | $199M | $157M | $158M |
| EBIT Avg | $48M | $51M | $58M | $55M | $56M |
| Low | $46M | $50M | $51M | $53M | $53M |
| High | $52M | $53M | $74M | $59M | $59M |
| Net Income Avg | $132M | $159M | $217M | $204M | $219M |
| Low | $127M | $146M | $216M | $193M | $207M |
| High | $136M | $173M | $247M | $221M | $237M |
| EPS Avg | $2.92 | $3.54 | $5.08 | $4.54 | $4.87 |
| Low | $2.83 | $3.24 | $4.79 | $4.28 | $4.59 |
| High | $3.02 | $3.84 | $5.49 | $4.91 | $5.27 |
| Analysts (Rev / EPS) | 3 / 2 | 4 / 3 | 4 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $184M | $202M | $180M | $192M | $193M | $210M |
| Low | $184M | $200M | $177M | $188M | $189M | $205M |
| High | $185M | $205M | $183M | $195M | $196M | $213M |
| EBITDA Avg | $32M | $35M | $31M | $33M | $33M | $36M |
| Low | $32M | $34M | $30M | $32M | $33M | $35M |
| High | $32M | $35M | $32M | $34M | $34M | $37M |
| EBIT Avg | $12M | $13M | $12M | $12M | $12M | $13M |
| Low | $12M | $13M | $11M | $12M | $12M | $13M |
| High | $12M | $13M | $12M | $13M | $13M | $14M |
| Net Income Avg | $31M | $34M | $30M | $31M | $35M | $39M |
| Low | $28M | $29M | $29M | $31M | $34M | $38M |
| High | $33M | $37M | $31M | $32M | $36M | $40M |
| EPS Avg | $0.76 | $0.84 | $0.75 | $0.78 | $0.87 | $0.97 |
| Low | $0.69 | $0.73 | $0.73 | $0.76 | $0.84 | $0.95 |
| High | $0.82 | $0.93 | $0.76 | $0.80 | $0.88 | $0.99 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |